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Background: The COVID-19 pandemic has led to significant changes in daily routines and lifestyle 
worldwide and mental health issues have emerged as a consequence. We aimed to assess the presence of sleep 
disturbances during the lockdown in the general population.
Methods: Cross-sectional, online survey-based study on adults living through the COVID-19 pandemic. 
The questionnaire included demographics and specific questions assessing the impact of the pandemic/
lockdown on sleep, daytime functioning and mental health in the general population. Identification of sleep 
pattern changes and specific sleep-related symptoms was the primary outcome, and secondary outcomes 
involved identifying sleep disturbances for predefined cohorts (participants reporting impact on mental 
health, self-isolation, keyworker status, suspected COVID-19 or ongoing COVID-19 symptoms). 
Results: In total, 843 participants were included in the analysis. The majority were female (67.4%), middle 
aged [52 years (40–63 years)], white (92.2%) and overweight to obese [BMI 29.4 kg/m2 (24.1–35.5 kg/m2)]; 
69.4% reported a change in their sleep pattern, less than half (44.7%) had refreshing sleep, and 45.6% were 
sleepier than before the lockdown; 33.9% had to self-isolate, 65.2% reported an impact on their mental 
health and 25.9% were drinking more alcohol during the lockdown. More frequently reported observations 
specific to sleep were ‘disrupted sleep’ (42.3%), ‘falling asleep unintentionally’ (35.2%), ‘difficulties 
falling’/‘staying asleep’ (30.9% and 30.8%, respectively) and ‘later bedtimes’ (30.0%). Respondents with 
suspected COVID-19 had more nightmares and abnormal sleep rhythms. An impact on mental health was 
strongly associated with sleep-related alterations.
Conclusions: Sleep disturbances have affected a substantial proportion of the general population during 
the COVID-19 pandemic lockdown. These are significantly associated with a self-assessed impact on mental 
health, but may also be related to suspected COVID-19 status, changes in habits and self-isolation. 
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Introduction
In December 2019, an outbreak of the novel strain severe 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
emerged in China, and rapidly spread worldwide. The new 
condition was named coronavirus disease 2019 (COVID-19) 
by the World Health Organization (WHO) and was 
declared a pandemic on the 11th of March 2020 (1). Millions 
of cases were confirmed with hundreds of thousands of 
deaths. This unprecedented situation and the finding 
that the virus was highly contagious (person-to-person 
transmission) (2), required the adoption of non-vaccination 
public health measures aiming to reduce further spreading 
of SARS-CoV-2 (2). These measures included track-
and-tracing, self-isolation, quarantine, social distancing 
and community containment, as well as nationwide 
lockdowns (3). Lockdown measures were implemented in 
many countries, including the UK, leading to significant 
social and lifestyle changes. In addition to any direct effects 
of COVID-19 on people’s health the lockdown had an 
impact on the perception of confinement, caused worries 
about livelihood, family or friends, and had indirect effects 
on the health and wellbeing of non-infected people. The 
psychological consequences of isolation in epidemics or 
during quarantine have previously been addressed (4,5), 
however, with scarce focus on their effects on sleep (6). 
In the current pandemic, the effects of isolation have 
been described in cohorts from China and Italy (7,8), with 
poor quality sleep and comorbid psychological disturbances 
being identified as significant issues (9-11). We therefore 
hypothesised that the COVID-19 pandemic and the public 
lockdown significantly impacted on sleep in the general 
population. We compared suspected COVID-19 with non-
COVID-19, and tested whether there was an association 
with mental health impact. In order to survey current sleep 
problems, the British Sleep Society (BSS) initiated the 
National Early Detection Screening for the COVID-19 
pandemic.
We present this  article in accordance with the 
“Strengthening the Reporting of Observational Studies in 




The BSS Research and Executive Committee approved this 
prospective, cross-sectional, survey-based study. The UKRI/
MRC and the NHS Health Research Authority (HRA) 
confirmed that ethical approval was not required owing 
to the screening survey design (https://cdn.amegroups.cn/
static/application/04712039f3b0c07e77f3c779c14d1a17/
JTD-CUS-2020-015-1.pdf). The study conformed to the 
provisions of the Declaration of Helsinki (as revised in 
2003). An online survey was available to the general public 
from May 12th to June 2nd, 2020 (https://cdn.amegroups.
cn/static/application/1778ae9dd49ffd9dfb1da63b6542
1e93/JTD-CUS-2020-015-2.pdf). Eligible participants 
were adults aged 18 years or older, living through the 
2020 COVID-19 pandemic and under national lockdown 
regulations. Subjects required literacy and access to the 
Internet. Participants were excluded if they were not living 
under national lockdown regulations or were underage.
Questionnaire items
Respondents were asked to answer multiple choice 
questions or provide a free-text response regarding baseline 
characteristics, and the impact of the pandemic/lockdown 
including COVID-19 infection history, self-isolation, key-
working, mental health, alcohol and sleep medication use, 
and a sleep profile (current quality/quantity, change in 




A total of 24 different sleep symptoms were grouped 
into six sleep symptom categories for analysis (Table S1): 
(I) insomnia/disrupted sleep, (II) daytime symptoms, 
(III) abnormal behaviours in sleep, (IV) sleep-disordered 
breathing, (V) restless legs, (VI) sleep phase disturbance.
Primary and secondary outcomes
The primary outcomes were to identify sleep disturbances 
related to the COVID-19 pandemic lockdown in the 
general population. Secondary outcomes included subgroup 
analyses for pre-defined cohorts within the population: 
reported suspected COVID-19, self-isolation, keyworker 
and mental health impact.
Statistical analysis
Cont inuous  var iab les  were  presented as  median 
[interquartile range, IQR], due to non-normally distributed 
data. Mann-Whitney U and Chi-squared analyses were 
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performed for comparison of continuous and categorical 
variables, respectively, in a priori subgroup comparison. 
A main-effects multiple logistic regression was used 
to identify the strength of association between the six 
symptom categories or a reported sleep pattern change and 
factors relating to the pandemic. Further multiple logistic 
regression modelling was reported as odds ratios where 
significant associations were found between sleep symptoms 
and pandemic-related factors (Supplementary material). 
‘Yes’ and ‘maybe’ responses regarding COVID-19 
infection were grouped into ‘suspected COVID-19’ for 
analysis due to global limited availability of polymerase 
chain reaction (PCR) swab testing. “Don’t know” answers 
were not included in the modelling as they were non-binary.
Data were collected on Google Forms (accessed online 
May 2020, Google Ireland Limited, Dublin, Ireland) and 
analysed with SPSS version 24 (IBM Corporation, New 
York, USA) and Prism version 8 (GraphPad Software, San 
Diego, California, USA). A P value of ≤0.05 was considered 
statistically significant. Missing data were not imputed.
Results
Demographics and descriptive characteristics
844 participants completed the online survey, one underage 
participant was excluded, and 843 datasets were included in 
the final analysis. Respondents were mostly female (67.4%), 
middle aged [52 years (40–63 years)], predominantly 
white (92.2%), and overweight to obese [BMI 29.4 kg/m2 
(24.1–35.5 kg/m2)] (Table 1). 
A proportion of 21.1% of respondents had suspected 
COVID-19 and 286 participants (33.9%) had to self-
isolate. 550 participants (65.2%) reported an impact of the 
pandemic on their mental health. 296 participants (35.1%) 
Table 1 Baseline characteristics of total study participants (n=843)
Characteristics Category N % or range
Gender Female 568 67.4%
Male 266 31.6%
Prefer not to say 3 0.4%
Other 6 0.7%
Age (years) 52 40–63












Weight (kg) 83.5 69.0–101.6
Height (cm) 167 160–175
BMI (kg/m2) 29.4 24.1–35.5
Data presented as count (percentage) or median [interquartile range].
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were keyworkers; 219 participants (25.9%) reported 
drinking more alcohol during the pandemic (Table S2). 
Impact on sleep
Less than half of the participants (47.5%) felt satisfied with 
their current sleep quantity or felt refreshed from sleep 
(44.7%), with 27.0% reporting to sleep 6–7 [5; 8] hours; 
585 participants (69.4%) noticed a change in their sleep 
pattern during the pandemic, 45.6% felt sleepier than 
before the lockdown and 7.4% reported the use of sleep 
medication during the lockdown compared to 5.2% before 
the lockdown (Table S3); 264 (31.3%) participants reported 
sleep restriction, with <6 hours of sleep. These were older 
[55 years (42–64 years) vs. 50 (39–62 years), P=0.007), had 
higher BMI [31.3 (25.7–37.6) vs. 28.3 (23.6–34.4) kg/m2, 
P<0.001], and were more likely to report shielding due 
to vulnerability (31.1% vs. 22.8%, P=0.038), disability 
(30.3% vs. 20.0%, P=0.001) and an impact on their mental 
health (71.2% vs. 62.5%, P=0.049) (Table S4).
The most commonly reported specific sleep symptoms 
were disrupted sleep (42.3%), falling asleep unintentionally 
(35.2%), difficulty falling and staying asleep (30.9% and 
30.8%, respectively) and going to bed later (30.0%) (Table 2). 
Regarding ‘other’ symptoms, a small number of respondents 
stated that their sleep had improved (1.9%) (Table S5).
Effect of self-isolation and keyworker status
A positive answer to household self-isolation status question 
was assumed to report the participants self-isolating 
themselves. Five cases were excluded from keyworker group 
comparison due to “don’t know” responses. 
Participants who self-isolated reported significantly 
more insomnia/disrupted sleep (60.8% vs. 51.7%, P=0.012), 
daytime symptoms (53.8% vs. 46.0%, P=0.030), abnormal 
behaviours in sleep (27.3% vs. 20.1%, P=0.018) and restless 
legs (23.4% vs. 16.2%, P=0.01) (Table 3); specifically, 
these reported more sleep disruption (49.3% vs. 38.8%, 
P=0.003), nightmares (24.1% vs. 16.5%, P=0.008), 
abnormal movements of the limbs/trunk (8% vs. 3.1%, 
P=0.001), restless legs (18.2% vs. 11.1%, P=0.005), falling 
asleep unintentionally (40.6% vs. 32.5%, P=0.02) and 
abnormal sleep rhythm (9.1% vs. 4.8%, P=0.016) (Table S6). 
Keyworkers described significantly fewer sleep-related and 
daytime disturbances than others, namely choking/gasping 
at night (1.7% vs. 5.4%, P=0.010), daytime naps (14.9% vs. 
23.7%, P=0.003), falls/injuries (0.3% vs. 2.2%, P=0.035) 
and getting up later (17.6% vs. 23.8%, P=0.035) (Table S7). 
Suspected COVID-19 status
The most reported COVID-19 infection symptoms in the 
total study participants were dry cough and breathlessness 
(4.5% each), followed by headache (3.7%) and muscle pain 
(3.6%) (Table S8). Participants with suspected COVID-19 
had significantly more nightmares (25.8% vs. 17.3%, 
P=0.010) and abnormal sleep rhythm (11.2% vs. 5.0%, 
P=0.002) (Table S9). Ongoing COVID-19 symptoms were 
associated with sleep disruption (OR 2.810, 95% CI, 1.632 
to 4.867, P<0.001) (Figure 1).
Mental health
Forty “don’t know” responses were excluded from mental 
health impact group comparison. Participants reporting 
an impact of the pandemic on their mental health also had 
significantly more sleep symptoms {5 [2–7] vs. 0 [0–3], 
P<0.001} and were more concerned about their sleep {6 
[5–8] vs. 4 [1–6] out of 10 points, P<0.001} (Table 3). A 
multiple logistic regression analysis demonstrated that 
reported mental health impact was a predictor of sleep 
pattern change during the pandemic (β=0.969, 95% CI, 
0.663 to 1.281, P<0.001, Table S10). In a further regression 
analysis, an impact on mental health was significantly 
predicted by the presence of difficulty falling asleep (OR 
3.600, 95% CI, 2.317 to 5.752, P<0.001), sleep disruption 
(OR 2.523, 95% CI, 1.696 to 3.794, P<0.001), excessive 
sleepiness (OR 3.488, 95% CI, 2.050 to 6.264, P<0.001), 
falling asleep unintentionally (OR 3.810, 95% CI, 2.588 to 
5.726, P<0.001) and nightmares (OR 7.005, 95% CI, 3.951 
to 13.600, P<0.001) (Figure 2). An impact on mental health 
was associated with both increased alcohol intake (OR 1.529, 
95% CI, 1.074 to 2.203, P=0.02) and sleep medication use 
(OR 1.634, 95% CI, 1.036 to 2.644, P=0.039).
Predictors of a change in sleep pattern
A multiple logistic regression model including ‘change 
in sleep pattern’ as the categorical outcome variable with 
baseline demographics and pandemic-related factors as 
predictor variables was performed (Table S10). No co-
linearity was found between predictor variables. A change 
in sleep pattern was overall most strongly associated 
with reported sleep medication use during the pandemic 
(β=1.276, 95% CI, 0.140 to 2.578, P=0.039), ongoing 
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Table 2 Reported specific sleep symptoms and within categories by total study participants (n=843)
Variables N % or range
Number of sleep symptoms 3 0–6
Insomnia/disrupted sleep 462 54.8%
Disrupted sleep 357 42.3%
Difficulty falling asleep 261 30.9%
Difficulty staying sleep 260 30.8%
Sleep phase disturbance 440 52.3%
Going to bed later 253 30.0%
Getting up later 183 21.7%
Getting up earlier 133 15.8%
Going to bed earlier 104 12.3%
Abnormal sleep rhythm (advanced/delayed) 53 6.3%
Daytime symptoms 410 48.6%
Falling asleep unintentionally 297 35.2%
Daytime naps 173 20.5%
Excessive sleepiness 168 19.9%
Falls/injuries 13 1.5%
Sleep-disordered breathing 223 26.5%
Morning headaches 179 21.2%
Breathlessness during the night 47 5.6%
Choking/gasping at night 34 4.0%
Breath-holding 30 3.6%
Abnormal behaviours in sleep 190 22.5%
Nightmares 161 19.1%
Sleep talking 27 3.2%
Sleep paralysis 22 2.6%
Sleepwalking 6 0.7%
Eating while asleep 6 0.7%
Restless legs 157 18.6%
Restless legs 114 13.5%
Cramps 51 6.0%
Abnormal movements (limbs or trunk) 40 4.7%
How concerned are you about your sleep? (0–10) 6 4–7
Data presented as count (percentage) or median [interquartile range].
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Table 3 Sleep symptom categories reported by study participants within subgroups
Groups Category
No Yes 
χ2 or MWU P value
N % or range N % or range
Suspected COVID-19 Number of sleep symptoms 3 0–6 4 0–6 56,821 0.406
Insomnia/disrupted sleep 354 53.2% 108 60.7% 3.139 0.076
Daytime symptoms 320 48.0% 90 50.6% 0.335 0.563
Abnormal behaviours in sleep 143 21.5% 47 26.4% 1.932 0.165
Sleep-disordered breathing 181 27.2% 42 23.6% 0.947 0.330
Restless legs 125 18.8% 32 18.0% 0.062 0.803
Sleep phase disturbance 353 53.1% 88 49.4% 0.748 0.387
How concerned are you about 
your sleep? (0–10)
6 4–7 6 4–8 21330 0.326
Self-isolation Number of sleep symptoms 3 0–6 4 1–7 70,651 0.006
Insomnia/disrupted sleep 288 51.7% 174 60.8% 6.365 0.012
Daytime symptoms 256 46.0% 154 53.8% 4.704 0.030
Abnormal behaviours in sleep 112 20.1% 78 27.3% 5.557 0.018
Sleep-disordered breathing 143 25.7% 80 28.0% 0.513 0.474
Restless legs 90 16.2% 67 23.4% 6.588 0.010
Sleep phase disturbance 291 52.2% 150 52.4% 0.003 0.955
How concerned are you about 
your sleep? (0–10)
6 4–7 6 4–8 26965 0.115
Keyworkers Number of sleep symptoms 3 0–6 3 0–6 74,972 0.123
Insomnia/disrupted sleep 292 54.0% 166 56.1% 0.686 0.558
Daytime symptoms 273 50.5% 134 45.3% 2.069 0.151
Abnormal behaviours in sleep 131 24.2% 56 18.9% 5.683 0.079
Sleep-disordered breathing 157 29.0% 64 21.6% 5.530 0.020
Restless legs 109 20.1% 48 16.2% 3.334 0.164
Sleep phase disturbance 291 53.8% 147 49.7% 1.319 0.253
How concerned are you about 
your sleep? (0–10)
6 4–7 6 4–7 27,592 0.369
Mental health Number of sleep symptoms 0 0–3 5 2–7 34,296 <0.001
Insomnia/disrupted sleep 72 28.3% 377 68.4% 118.238 <0.001
Daytime symptoms 60 23.6% 338 61.3% 104.778 <0.001
Abnormal behaviours in sleep 16 6.3% 170 30.9% 63.810 <0.001
Sleep-disordered breathing 34 13.4% 181 32.8% 34.783 <0.001
Restless legs 23 9.1% 127 23.0% 22.599 <0.001
Sleep phase disturbance 89 35.0% 336 61.1% 49.360 <0.001
How concerned are you about 
your sleep? (0–10)
4 1–6 6 5–8 11,789 <0.001
Suspected COVID-19: no (n=665), yes (n=178); self-isolation: no (n=557), yes n=286; keyworkers: no (n=541), yes n=296; mental health: 
no (n=254), yes (n=549). Data presented as count (percentage) and median [interquartile range]. χ2 = Chi-squared values presented for 
categorical variables. MWU = Mann-Whitney U values presented for scale variables.
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Figure 1 Forest plot displaying associations between ongoing COVID-19 symptoms and reported sleep symptoms (for all sleep symptom 
categories and specific symptoms within insomnia/disrupted sleep category). (A) Odds ratios for sleep symptom categories. (B) Odds ratios 
for specific sleep symptoms within insomnia/disrupted sleep category.
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Figure 2 Forest plots displaying significant associations between mental health impact and sleep symptoms (by symptom category, and 
specific sleep symptoms reported within insomnia/disrupted sleep, daytime symptoms and abnormal behaviours in sleep categories). (A) 
Odds ratios for the six sleep symptom categories. (B) Odds ratios for insomnia/disrupted sleep. (C) Odds ratios for daytime symptoms. (D) 
Odds ratios for abnormal behaviours in sleep. Sleepwalking and eating while sleeping excluded due to perfect separation.
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COVID-19 symptoms (β=1.124, 95% CI, 0.368 to 1.937, 
P=0.005) and reported mental health impact (β=0.969, 
95% CI, 0.663 to 1.281, P<0.001), displaying a negative 
association with age (β=−0.026, 95% CI, −0.040 to −0.012, 
P<0.001), male gender (β=−0.350, 95% CI, −0.658 to 
−0.040, P=0.026) and general health rating (β=−0.244, 95% 
CI, −0.343 to −0.149, P<0.001) (Tjur’s R2=0.177, adjusted 
R2=0.165).
Association between sleep symptom categories and 
pandemic factors 
Insomnia/disrupted sleep was significantly associated with 
mental health impact (OR 2.435, 95% CI, 1.821 to 3.281, 
P<0.001), ongoing COVID-19 symptoms (OR 2.232, 95% 
CI, 1.159 to 4.385, P=0.018) and sleep medication use 
during the pandemic (OR 5.933, 95% CI, 2.142 to 20.030, 
P=0.002). Daytime symptoms were significantly associated 
with an impact on mental health (OR 2.332, 95% CI, 1.741 
to 3.145, P<0.001) and sleep medication use during the 
pandemic (OR 3.450, 95% CI, 1.425 to 9.285, P=0.009). 
Abnormal behaviours in sleep were significantly associated 
with mental health impact (OR 2.198, 95% CI, 1.522 to 
3.212, P<0.001) and reported disability (OR 1.504, 95% 
CI, 1.002 to 2.253, P=0.048). Sleep-disordered breathing 
was significantly associated with ongoing COVID-19 
symptoms (OR 3.405, 95% CI, 1.610 to 7.450, P=0.002) 
and an impact on mental health (OR 1.725, 95% CI, 
1.232 to 2.430, P=0.002). Restless legs symptoms were 
significantly associated with ongoing COVID-19 symptoms 
(OR 2.530, 95% CI, 1.143 to 5.388, P=0.024), an impact on 
mental health (OR 1.933, 95% CI, 1.318 to 2.862, P=0.001) 
and reported disability (OR 1.566, 95% CI, 1.029 to 
2.364, P=0.034). Sleep phase disturbance was significantly 
associated with an impact on mental health (OR 1.669, 
95% CI, 1.254 to 2.212, P<0.001), increased alcohol intake 
(OR 1.510, 95% CI, 1.080 to 2.121, P=0.017) and sleep 
medication use during the pandemic (OR 2.553, 95% CI, 
1.084 to 6.713, P=0.041) (Figure 3).
Discussion
Summary of main findings
The pandemic lockdown had a major impact on the 
population. The majority of respondents described 
an altered sleep pattern and almost half of the studied 
population felt sleepier than prior to the lockdown. 
Reported problems included dozing off unintentionally in 
the day, disrupted sleep, difficulties falling/staying asleep 
and later bedtimes. Over a quarter of all respondents 
reported an increased alcohol intake during the lockdown. 
Furthermore, those self-isolating reported more insomnia/
disrupted sleep, daytime symptoms, abnormal behaviours 
in sleep and symptoms of restless legs compared to those 
not self-isolating. Keyworkers reported fewer sleep 
alterations than others. In those with suspected COVID-19, 
nightmares and abnormal sleep rhythm were more 
common. A reported impact on mental health was most 
strongly associated with more difficulties falling asleep, 
sleep disruption, nightmares and daytime sleepiness. A 
change in sleep pattern was associated with medication use, 
ongoing COVID-19 symptoms and mental health impact, 
and it was negatively associated with age, male gender and 
general health. 
Assessing lockdown impact on sleep and clinical significance 
of findings
Home confinement and isolation procedures have required 
modifications in lifestyle, leading to the loss of daily 
routines and habits. Resultant issues such as work, family 
and financial problems, limited exposure to natural light, 
and restricted opportunities to exercise may have negative 
effects on sleep (5). Insufficient sunlight, physical inactivity, 
dietary changes, weight gain, increased digital screen time, 
as well as the risk of alcohol use and developing addictions, 
are associated with prolonged lockdown (12). Additionally, 
sleep deprivation may lead to immunological alterations 
and it would therefore seem pertinent to consider the 
effects of altered sleep on COVID-19 susceptibility (13). 
Notably, almost a third of participants in our study reported 
sleeping less than 6 hours, and these were of older age, had 
higher BMI, reported more vulnerability/disability and 
mental health impact during the pandemic compared to 
respondents getting more than 6 hours of sleep. 
Reported change in sleep pattern and specific sleep 
symptoms
Less than half of our study participants were feeling 
refreshed or felt that they were sleeping enough during 
the pandemic, and almost half of them felt sleepier than 
before the lockdown (Table S3). The most commonly 
reported specific sleep symptoms included disrupted sleep, 
difficulty falling and staying asleep, later bedtimes and 
falling asleep unintentionally in the day (Table 2). A majority 
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Figure 3 Forest plots displaying association of each sleep symptom category (insomnia/disrupted sleep, daytime sleepiness, abnormal 
behaviours in sleep, sleep-disordered breathing, restless legs, sleep phase disturbance) with demographics and pandemic-related factors. 
(A) Odds ratios for insomnia/disrupted sleep. (B) Odds ratios for daytime symptoms. (C) Odds ratios for abnormal behaviours in sleep. (D) 
Odds ratios for sleep-disordered breathing. (E) Odds ratios for restless legs symptoms. (F) Odds ratios for sleep phase disturbance.
of respondents reported a change in sleep pattern, and 
this was predicted by the presence of ongoing COVID-19 
symptoms, mental health impact, sleep medication use in 
the pandemic, younger age and worse general health rating 
(Table S10). Similarly, a recent Italian survey including young 
adults demonstrated a significantly delayed bed and rise 
times during lockdown, spending overall more time in bed, 
but reporting a poor sleep quality (8). Also, an increased 
prevalence of insomnia during the outbreak was found in a 
Chinese survey-based study (9). Of note, a UK survey showed 
that half of the respondents experienced more disturbed sleep 
than usual; 39% of the participants reported sleeping fewer 
hours than before the lockdown; and 29% reported sleeping 
longer hours but still felt less rested (14). Consistent with our 
findings, only a minority of respondents reported improved 
sleep during the lockdown (14). 
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Effect of alcohol 
Although frequently used by people who suffer from 
insomnia to try and help sleep (15), alcohol actually 
disrupts sleep architecture, possibly exacerbates sleep 
pathologies (such as sleep-disordered breathing and NREM 
parasomnias), and worsens daytime sleepiness (16). Almost 
26% of our study population reported increased alcohol 
intake during the lockdown (Table S2). This is in line with 
previous evidence showing that, despite the decrease in 
social gathering, only a third of drinkers have reduced 
or stopped their alcohol intake, while 21% drink more 
frequently (17). Stress further contributes to alcohol seeking 
behaviour (18), and alcohol is also used to alleviate negative 
emotions (19). In our study, the presence of a sleep phase 
disturbance was predicted by an increased alcohol intake, 
reported mental health impact and sleep medication use 
during the pandemic (Figure 3).
Impact on mental health
The potential effect of mood alterations on sleep is 
relevant in the pandemic. The link between sleep and 
mood disturbances has previously been demonstrated 
in circumstances similar to the current lockdown (4,5). 
Confinement and quarantine have negative psychological 
consequences (4,5), which can have an impact on sleep. 
Worsened insomnia symptoms and psychological reactions 
attributed to the outbreak were demonstrated in the general 
population using online questionnaires reflecting the 
situation prior to and following the lockdown (9). Insomnia 
was associated with being female, mental illness, increased 
severity of anxiety and depression, COVID-19-related 
stress and prolonged time in bed (9). In a Chinese study 
the prevalence of insomnia was at 26%, and over 20% of 
patients with pre-existing mental health conditions reported 
a deterioration of these (11). Stronger changes in sleep 
quality in those with higher scores of depression, anxiety 
and stress were reported as well. Additionally, a longitudinal 
study investigating whether sleep quality depends on 
the social situation found an association between social 
isolation and poor sleep quality in older adults (20). Of 
note, over 65% of the population involved in our study 
reported an impact of the pandemic or lockdown on their 
mental health (Table S2), and this cohort reported more 
sleep-related symptoms and concerns about their sleep 
(Table 3). Importantly, an impact on mental health was one 
of the significant predictors for a reported change in sleep 
pattern (Table S10). On regression analysis, reported mental 
health impact was significantly associated with difficulties 
falling asleep, disrupted sleep, daytime sleepiness and 
nightmares (Figure 2).
Self-isolation status, keyworkers and sleep
Compared to those who did not self-isolate, self-isolators 
more frequently reported disrupted sleep, nightmares, 
abnormal movements,  restless legs,  fal l ing asleep 
unintentionally and abnormal sleep rhythm (Table S6). 
Higher rates of difficulties to fall asleep or early awakenings 
in medically isolated versus self- or non-isolated individuals 
in the outbreak have been previously demonstrated (7). 
A subgroup of the population that deserves special attention 
in the current circumstances are keyworkers. Healthcare 
workers account for a proportion of these; they have not 
only suffered the stress of being directly involved in the 
care of patients, but also faced the consequences of working 
long hours during the pandemic. Sleep disruption, poor 
quality of sleep, insomnia, and mood disturbances have 
all been reported in healthcare workers under pandemic 
circumstances (21-23). Although our study did not find 
an association between sleep disturbances and keyworker 
status, notably this group also included non-healthcare 
workers (postal workers, truck driver, police officer and 
others) (Table S7). Possibly keyworkers, considered as a 
wider group, experienced fewer changes in their routines 
during the lockdown, as they were allowed to leave the 
house to continue working.
Suspected COVID-19
There may be additional factors affecting sleep directly 
when considering individuals who suspect they have 
had COVID-19. Pre-existing sleep disorders, such as 
obstructive sleep apnoea, may also be present in COVID-19 
patients (24), and might further impact on sleep quality and 
shortness of breath following the infection. In our study, 
the presence of symptoms associated with sleep-disordered 
breathing was significantly associated with ongoing 
COVID-19 symptoms (Figure 3). 
Furthermore, potential neuropathogenic mechanisms of 
SARS-CoV-2 and a range of neurological symptoms have 
been reported in patients with COVID-19 (25). It could 
be hypothesised that involvement of structures controlling 
sleep-wake cycles in the central nervous system play a role 
in the presence of sleep-related symptoms in COVID-19 
patients. We found a significant association between the 
presence of ongoing COVID-19 symptoms and insomnia/
disrupted sleep (Figure 3). Moreover, participants with 
suspected COVID-19 had a higher frequency of nightmares 
S173Journal of Thoracic Disease, Vol 12, Suppl 2 October 2020
© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2020;12(Suppl 2):S163-S175 | http://dx.doi.org/10.21037/jtd-cus-2020-015
and abnormal sleep rhythm (Table S9). Additionally, our 
regression analysis showed that restless legs symptoms were 
significantly associated with ongoing COVID-19 symptoms, 
mental health impact, and disability (Figure 3). 
Limitations to the study
A selection bias may be expected in the study, as subjects 
with affected sleep may have been more interested in 
completing the survey. Also, as the survey was widely 
distributed among the population, this could have included 
subjects living in different countries, with different levels of 
lockdown measures. Additionally, the self-reported status 
with regards to having suspected COVID-19 was subjective 
and affirmatory responses did not require positive formal 
testing. Moreover, no formal objective assessments of 
specific sleep disorders were undertaken. Finally, there was 
limited diversity in the respondents’ ethnicity which did 
not permit assessing the impact of the pandemic on sleep in 
ethnic minorities. 
Despite these limitations, and although it is clear that 
public health measures are required in such unprecedented 
circumstances, the potential effects of confinement and 
isolation on sleep should be screened for, and support needs to 
be provided for adequate management of sleep disturbances (6). 
Early identification of sleep disturbances and associated impact 
on mental health is crucial for timely intervention and support 
(26,27). Future studies could include formal assessments of 
subjective and objective measurements of sleep disorders, 
with more specific focus on subgroups according to infection, 
keyworker status and ethnicity.
Conclusions
Altered sleep patterns and specific sleep-related symptoms 
are common in the general population during the pandemic 
lockdown. These are mainly associated with mental health 
impact, self-isolation, suspected COVID-19 infection and 
ongoing symptoms. The potential consequences of the 
lockdown on sleep should not be overlooked, as they can 
have an impact on the future wellbeing of society. Sleep 
issues may be addressed early with appropriate guidance 
and/or counselling to avoid the longer-term impact of these 
on a public health scale.
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Following internal discussions in the research committee, 
the BSS undertook a prospective, cross-sectional, survey-
based study that was conducted from May 12th, 2020 to June 
2nd, 2020, available to the general public. The survey was 
advertised via the BSS webpage, social media, NHS hospital 
trusts and specialist society and patient charities networks. 
The survey was submitted to the UKRI/MRC and the 
NHS Health Research Authority (HRA) ‘is it research?’ 
tool, confirming that ethical approval was not required 
(http://www.hra-decisiontools.org.uk/research/result7.
html; outcome of assessment in https://cdn.amegroups.cn/
static/application/04712039f3b0c07e77f3c779c14d1a17/
JTD-CUS-2020-015-1.pdf; 09/05/2020). It was approved 
internally by the BSS Research and Executive Committees 
(11/05/2020; BSS-NEDS-SURVEY_V1-0; Appendix 2) 
and distributed via Google Forms on an open domain on 
May 12th, 2020. Data collection stopped on June 2nd, 2020. 
Eligible participants were adults aged 18 years, or older, 
living through the 2020 COVID-19 pandemic and under 
national lockdown regulations. Due to the nature of the 
survey, subjects required literacy and access to the Internet. 
Participants were excluded if they were not living under 
national lockdown regulations or were underage.
Questionnaire items
Participants were asked to read an introduction preceding 
the questionnaire items outlining the nature and purpose 
of the survey and the interested bodies (BSS). Following 
an item reduction phases involving specialists from all 
participating affiliations, respondents were asked to answer 
multiple choice questions, including “yes”, “no”, “don’t 
know” and context- specific answers, or provide a free-text 
response to “other, please specify”.
The following demographics were collected:
 Age (years);




 Body-mass-index (BMI), calculated by weight (kg)/
height (m2);
 Keyworker status (yes/no);
 Disability (yes/no/don’t know);
 Need to shield due to vulnerability status (yes/no/
don’t know).
Specific questions to assess the impact of the pandemic/
lockdown related to the following:
 Suspected COVID-19 history [yes/no/maybe 
(possibly, but they had no test)];
 Ongoing COVID-19 symptoms (tick all that 
apply: no/dry cough/sore throat/headache/fever/
breathlessness/shortness of breath/chest pain/muscle 
pain/leg pain/loss of smell/skin rash/other);
 Self-isolation history in household (yes/no);
 Impact of the pandemic on mental health (yes/no/
don’t know);
 Currently feeling refreshed from sleep (yes/no/
undecided);
 Current feeling of sleeping enough (yes/no);
 Current sleep quantity (tick all that apply: less than 4 
hours/4–5 hours/5–6 hours/6–7 hours/7–8 hours/8–9 
hours/9–10 hours/10–11 hours/11–12 hours/more 
than 12 hours);
 Change in sleep pattern during the pandemic (yes/no);
 Specific sleep symptoms (tick all that apply: 
difficulties falling asleep/difficulties staying asleep/
excessive sleepiness/disrupted sleep/nightmares/
sleep paralysis (unable to move when waking)/
sleepwalking/talking in your sleep/eating while 
asleep/abnormal movements (e.g., limbs or trunk)/
breathlessness/shortness of breath during the night/
breath holding/choking/gasping at night/night 
sweats/morning headache/restless legs/periodic limb 
movements/naps required by daytime/falls/injuries/
falling asleep unintentionally/cramps/abnormal sleep 
rhythm (advanced/delayed)/going to bed earlier/
going to bed later/getting up earlier/getting up later/
other);
 Daytime symptoms of fatigue and/or sleepiness 
compared to before the lockdown (yes/no/
undecided);
 Concern regarding sleep disturbance [rating on a 
scale from ‘0’ (worst) to ‘10’ (best)];
 Increased alcohol intake (yes/no/prefer not to say);
 Increased sleep medication use before and during the 
lockdown (yes/no/prefer not to say);
 Current rate of general health [scale from ‘0’ (worst) 
to ‘10’ (best)].
 Overweight was defined as BMI of 25–29.9 kg/m2 
and obesity was defined as BMI ≥30 kg/m2.
A total of 24 different sleep symptoms were grouped into 
six sleep symptom categories for analysis (Table S1):
(I) Insomnia/disrupted sleep;
(II) Daytime symptoms;
(III) Abnormal behaviours in sleep;
(IV) Sleep-disordered breathing;
(V) Restless legs;
(VI) Sleep phase disturbance.
Online links were provided for official guidance from 
the BSS regarding sleep and from the UK government 
regarding COVID-19. Participants were advised to contact 
the helplines provided (111/999) if they required urgent or 
emergent medical care
Primary and secondary outcomes
The primary outcomes were to identify sleep disturbances 
and specific sleep symptoms related to the COVID-19 
pandemic lockdown in the general population. Secondary 
outcomes included subgroup analyses for pre-defined 
cohorts within the population: suspected COVID-19, self-
isolation, keyworkers and those reporting an impact on 
mental health.
Statistical analysis
Continuous variables including demographics and scale 
ratings were presented as median [interquartile range, IQR], 
due to non-normally distributed data and Mann-Whitney 
U analysis was performed for comparison. Chi-squared 
analysis was performed to compare categorical variables. 
Group comparisons were made based on suspected 
COVID-19 vs non- infected, self-isolation, keyworker 
status and impact on mental health due to the COVID-19 
pandemic.
A multiple logistic regression model including ‘change 
in sleep pattern’ as the categorical outcome variable 
with ‘age’, ‘male gender’, ‘BMI’, ‘suspected COVID-19’, 
‘ongoing COVID-19 symptoms’, ‘self-isolation’, ‘impact 
on mental health’, ‘shielding due to vulnerability’, ‘alcohol 
use’, ‘global general health rating’, ‘keyworking’, ‘disability’, 
‘sleep medication before’ and ‘sleep medication during’, as 
predictor variables, was performed.
These variables were chosen due to their nature as either 
baseline demographics or pandemic- related factors.
A main-effects multiple logistic regression model was 
used to identify the strength of association and odds ratios 
with 95% CI between the six different symptom categories 
(insomnia/disrupted sleep, daytime symptoms, abnormal 
behaviours in sleep, sleep-disordered breathing, restless 
legs and sleep phase disturbance) and factors relating to 
the COVID-19 pandemic. Where significant associations 
were found, further multiple logistic regression modelling 
was performed and reported as odds ratios between sleep 
symptoms and factors relating to the COVID-19 pandemic.
‘Yes’ and ‘maybe’ responses regarding COVID-19 
infection were grouped into ‘suspected COVID-19’ for 
analysis due to the limited availability of polymerase chain 
reaction (PCR) swab testing to the general public and the 
small sample size of confirmed infected participants. “Don’t 
know” answers were not included in the modelling as they 
were non- binary.
Data were collected on Google Forms (accessed online 
May 2020, Google Ireland Limited, Dublin, Ireland) and 
exported using MS Excel (Microsoft, Version 2004, Seattle, 
WA, USA). Data were then imported into IBM SPSS 
version 24 (IBM Corporation, New York, USA) and Prism 
version 8 (GraphPad Software, San Diego, California, USA) 
for further analysis. A P value of ≤0.05 was considered 
statistically significant. Missing data were not included in 
the analysis based on case-by-case decision.
Table S1 Grouping of 24 specific sleep symptoms into six categories
Category Symptom
Insomnia/disrupted sleep Difficulty falling asleep
Difficulty staying asleep
Disrupted sleep













Restless legs Restless legs
Cramps
Abnormal movements (trunk or limbs)
Sleep phase disturbance Abnormal sleep rhythm (advanced or delayed)
Going to bed earlier
Going to bed later
Getting up earlier
Getting up later
Table S2 Health and social factors during the pandemic on total study participants (n=843)
Factors Category N % or range
Have you been infected with the COVID-19 virus? Yes 16 1.9%
Maybe 162 19.2%
Do you have ongoing symptoms? 84 10.0%




Have you or someone in your household needed to self-
isolate?
286 33.9%
Have you needed to shield as a vulnerable person? Yes 214 25.4%
Maybe 30 3.6%
Have you felt that the COVID-19 pandemic or the 
lockdown have had an impact on your mental health?
Yes 550 65.2%
Maybe 39 4.6%
Do you belong to any key worker group (e.g., NHS, public 
transport, post office, teacher, truck driver, and others)?
296 35.1%
Do you have any disability? 196 23.3%
Do you drink more alcohol than before the lockdown? 219 25.9%
How would you rate your health currently? (0–10) 7 5–8
Data presented as count (percentage) or median [interquartile range].
Table S3 General sleep-related information of total study participants (n=843)
Variables Category N % or range
Do you currently feel refreshed from sleep? 377 44.7%
Do you currently feel you sleep for long enough? 401 47.5%
How long do you currently sleep? (hours) 6–7 5–8
How long do you currently sleep? <4 hours 19 2.3%
4–5 hours 76 9.0%
5–6 hours 169 20.0%
6–7 hours 228 27.0%
7–8 hours 226 26.8%
8–9 hours 94 11.2%
9–10 hours 18 2.1%
10–11 hours 8 0.9%
11–12 hours 3 0.4%
>12 hours 2 0.2%
Have you noticed a change in your sleep pattern during the 
COVID-19 pandemic?
585 69.4%
Do you currently feel sleepier than before the lockdown? Yes 384 45.6%
Undecided 142 16.8%
Are you more easily fatigued or worn out when exercising 
compared to before the lockdown?
Yes 388 46.0%
Undecided 127 15.1%
Are you concerned about your sleep during the pandemic? 347 41.2%
How concerned are you about your sleep? (0–10) 6 4–7
Are you concerned about the sleep of someone in your family/
household?
244 28.9%
Did you take sleeping pills during the lockdown? 62 7.4%
Did you already take sleeping pills before the lockdown? 44 5.2%
Do you take any other sleep-related medication? 73 8.7%
Data presented as count (percentage) and median [interquartile range].
Table S4 Characteristics of participants with reported sleep restriction (<6 hours of sleep per night)
Characteristics
Sleep restriction (<6 hours of sleep)
No (n=619) Yes (n=224)
χ2 or MWU P value
N % or range N % or range
Age (years) 50 39–62 55 42–64 67,586 0.007
Gender
Female 384 66.3% 184 69.7% 2.218 0.528
Male 190 32.8% 76 28.8%
Prefer not to say 2 0.3% 1 0.4%
Other 3 0.5% 3 1.1%
BMI (kg/m2) 28.3 23.6–34.3 31.3 25.7–37.6 59,954 <0.001
Suspected COVID-19 125 21.6% 53 20.1% 0.249 0.618
Do you have ongoing symptoms? 62 10.7% 22 8.3% 1.140 0.286
Have you or someone in your household 
needed to self-isolate?
196 33.9% 90 34.1% 0.005 0.946
Have you needed to shield as a vulnerable 
person?
132 22.8% 82 31.1% 6.552 0.038
Have you felt that the COVID-19 pandemic 
or the lockdown have had an impact on your 
mental health?
362 62.5% 188 71.2% 6.041 0.049
Do you belong to any key worker group (e.g., 
NHS, public transport, post office, teacher, 
truck driver, and others)?
219 37.8% 77 29.2% 5.967 0.051
Do you have any disability? 116 20.0% 80 30.3% 14.696 0.001
Do you drink more alcohol than before the 
lockdown?
159 27.5% 60 22.7% 2.114 0.348
Did you take sleeping pills during the 
lockdown?
35 6.0% 27 10.2% 4.655 0.031
Did you already take sleeping pills before the 
lockdown?
26 4.5% 18 6.8% 3.313 0.191
Data presented as count (percentage) and median [interquartile range]. χ2 = Chi-squared values presented for categorical variables. 
MWU = Mann-Whitney U values presented for scale variables.







Work related sleep restriction 5
Childcare-related sleep restriction 4
Tachycardia/palpitations 3
Bruxism/tooth-grinding 3
Improved PAP adherence 2



















Data presented as counts. PAP, positive airway pressure.
Table S6 Specific sleep symptoms reported by self-isolators versus non self-isolators
Variables
Have you or someone in your household needed to self-isolate?
χ2 P valueNo (n=557) Yes (n=286)
N % N %
Difficulty falling asleep 162 29.1% 99 34.6% 2.705 0.100
Difficulty staying sleep 164 29.3% 97 33.9% 1.917 0.166
Excessive sleepiness 111 19.9% 57 19.9% 0.000 0.999
Disrupted sleep 216 38.8% 141 49.3% 8.568 0.003
Nightmares 92 16.5% 69 24.1% 7.081 0.008
Sleep paralysis 13 2.3% 9 3.1% 0.491 0.483
Sleepwalking 5 0.9% 1 0.3% 0.803 0.370
Sleep talking 16 2.9% 11 3.8% 0.578 0.447
Eating while asleep 3 0.5% 3 1.0% 0.696 0.404
Abnormal movements (limbs or trunk) 17 3.1% 23 8.0% 10.410 0.001
Breathlessness during the night 30 5.4% 17 5.9% 1.112 0.738
Breath-holding 18 3.2% 12 4.2% 0.512 0.474
Choking/gasping at night 20 3.6% 14 4.9% 0.831 0.362
Night sweats 72 12.9% 50 17.5% 3.169 0.075
Morning headaches 118 21.1% 61 21.3% 0.002 0.951
Restless legs 62 11.1% 52 18.2% 8.033 0.005
Daytime naps 98 17.6% 75 26.2% 8.628 0.003
Falls/injuries 6 1.1% 7 2.4% 2.337 0.126
Falling asleep unintentionally 181 32.5% 116 40.6% 5.385 0.020
Cramps 31 5.6% 20 7.0% 0.677 0.410
Abnormal sleep rhythm (advanced/
delayed)
27 4.8% 26 9.1% 5.776 0.016
Going to bed earlier 65 11.7% 39 13.6% 0.676 0.411
Going to bed later 173 31.1% 80 28.0% 0.857 0.354
Getting up earlier 81 14.5% 52 18.2% 1.884 0.170
Getting up later 130 23.3% 53 18.5% 2.570 0.109
Data presented as count (percentage). χ2 = Chi-squared values.
Table S7 Specific sleep symptoms reported by keyworkers versus non-keyworkers
Variables
Do you belong to any keyworker group (e.g., NHS, public transport, post 
office, teacher, truck driver, and others)?
χ2 P value
No (n=541) Yes (n=296)
N % N %
Difficulty falling asleep 165 30.5% 94 31.8% 0.157 0.707
Difficulty staying sleep 170 31.4% 88 29.7% 0.275 0.612
Excessive sleepiness 117 21.6% 48 16.2% 6.934 0.060
Disrupted sleep 225 41.6% 128 43.2% 1.678 0.643
Nightmares 109 20.1% 49 16.6% 5.334 0.204
Sleep paralysis 15 2.8% 6 2.0% 5.117 0.510
Sleepwalking 4 0.7% 2 0.7% 0.054 0.917
Sleep talking 17 3.1% 9 3.0% 3.540 0.935
Eating while asleep 4 0.7% 2 0.7% 0.054 0.917
Abnormal movements (limbs or trunk) 30 5.5% 10 3.4% 2.289 0.160
Breathlessness during the night 35 6.5% 11 3.7% 4.167 0.095
Breath-holding 21 3.9% 9 3.0% 0.617 0.531
Choking/gasping at night 29 5.4% 5 1.7% 6.916 0.010
Night sweats 80 14.8% 41 13.9% 0.159 0.713
Morning headaches 122 22.6% 55 18.6% 2.332 0.179
Restless legs 80 14.8% 34 11.5% 2.728 0.183
Daytime naps 128 23.7% 44 14.9% 9.129 0.003
Falls/injuries 12 2.2% 1 0.3% 4.550 0.035
Falling asleep unintentionally 192 35.5% 103 34.8% 0.050 0.841
Cramps 36 6.7% 15 5.1% 1.237 0.359
Abnormal sleep rhythm (advanced/
delayed)
32 5.9% 19 6.4% 7.585 0.771
Going to bed earlier 67 12.4% 37 12.5% 0.853 0.961
Going to bed later 172 31.8% 79 26.7% 2.404 0.123
Getting up earlier 85 15.7% 47 15.9% 0.008 0.950
Getting up later 129 23.8% 52 17.6% 4.916 0.035
Data presented as count (percentage). χ2 = Chi-squared values. “Don’t know” responses excluded from analysis (n=6).
Table S8 Reported symptoms of COVID-19 infection in participants with suspected COVID-19 status (n=178)
Variables N %
Dry cough 38 4.5%
Breathlessness 38 4.5%
Headache 31 3.7%
Muscle pain 30 3.6%
Other 23 2.7%
Sore throat 21 2.5%
Leg pain 20 2.4%
Chest pain 18 2.1%
Loss of smell 14 1.7%
Fever 11 1.3%
Skin rash 6 0.7%
Data presented as count (percentage).
Table S9 Specific sleep symptoms reported by suspected COVID-19 versus non-suspected COVID-19
Variables
Suspected COVID-19
χ2 P valueNo (n=665) Yes (n=178)
N % N %
Difficulty falling asleep 206 31.0% 55 30.9% 0.000 0.984
Difficulty staying sleep 204 30.7% 56 31.5% 0.040 0.841
Excessive sleepiness 131 19.7% 37 20.8% 0.104 0.747
Disrupted sleep 271 40.8% 86 48.3% 3.289 0.070
Nightmares 115 17.3% 46 25.8% 6.643 0.010
Sleep paralysis 17 2.6% 5 2.8% 0.035 0.851
Sleepwalking 4 0.6% 2 1.1% 0.542 0.462
Sleep talking 21 3.2% 6 3.4% 0.021 0.883
Eating while asleep 3 0.5% 3 1.7% 3.027 0.082
Abnormal movements (limbs or trunk) 28 4.2% 12 6.7% 1.990 0.158
Breathlessness during the night 40 6.0% 7 3.9% 1.157 0.282
Breath-holding 27 4.1% 3 1.7% 2.307 0.129
Choking/gasping at night 28 4.2% 6 3.4% 0.256 0.613
Night sweats 95 14.3% 27 15.2% 0.088 0.766
Morning headaches 146 22.0% 33 18.5% 0.979 0.322
Restless legs 89 13.4% 25 14.0% 0.053 0.819
Daytime naps 133 20.0% 40 22.5% 0.526 0.468
Falls/injuries 8 1.2% 5 2.8% 2.385 0.122
Falling asleep unintentionally 233 35.0% 64 36.0% 0.052 0.820
Cramps 39 5.9% 12 6.7% 0.190 0.663
Abnormal sleep rhythm (advanced/delayed) 33 5.0% 20 11.2% 9.380 0.002
Going to bed earlier 81 12.2% 23 12.9% 0.071 0.789
Going to bed later 201 30.2% 52 29.2% 0.068 0.794
Getting up earlier 101 15.2% 32 18.0% 0.822 0.365
Getting up later 153 23.0% 30 16.9% 3.128 0.738
Data presented as count (percentage). χ2 = Chi-squared values.
Table S10 Multiple logistic regression to assess association of 'change in sleep pattern’ with demographics and pandemic-related factors (Tjur’s 
R2=0.177, adjusted R2=0.165)
Variables β co-efficient 95% confidence intervals P value
Age (years) −0.026 −0.040 to −0.012 <0.001
Male −0.350 −0.658 to −0.040 0.026
BMI −0.011 −0.030 to 0.007 0.235
Suspected COVID-19 −0.355 −0.851 to 0.145 0.161
Ongoing COVID-19 symptoms 1.124 0.368 to 1.937 0.005
Self-isolation 0.232 −0.141 to 0.609 0.226
Mental health impact 0.969 0.663 to 1.281 <0.001
Shielding 0.0178 −0.387 to 0.428 0.932
Increased alcohol 0.297 −0.090 to 0.694 0.137
General health rating −0.244 −0.343 to −0.149 <0.001
Keyworkers −0.153 −0.513 to 0.209 0.405
Disability 0.148 −0.284 to 0.598 0.509
Sleep medication before −0.626 −1.817 to 0.515 0.287
Sleep medication during 1.276 0.140 to 2.578 0.039
